deltatrials
Terminated PHASE1 INTERVENTIONAL 6-arm NCT05160402

Evaluation of IGM-6268 in Healthy Volunteers

A Phase 1 Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Intranasal Plus Intraoral IGM-6268 in Healthy Volunteers

Sponsor: IGM Biosciences, Inc.

Conditions Healthy Volunteers
Interventions IGM-6268 Placebo
Updated 4 times since 2022 Last updated: Oct 12, 2022 Started: Dec 7, 2021 Primary completion: Jun 15, 2022 Completion: Aug 18, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor decision

Other terminated trials from IGM Biosciences, Inc.

More terminations from IGM Biosciences, Inc.

Other Healthy Volunteers trials with similar outcome

Browse all Healthy Volunteers trials

This PHASE1 trial investigates Healthy Volunteers and is currently terminated or withdrawn. IGM Biosciences, Inc. leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2022 – ~Nov 2022 · 10 months · monthly snapshotRecruiting~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  3. Nov 2022 — Jul 2024 [monthly]

    Terminated PHASE1

    Status: Recruiting → Terminated

  4. Jan 2022 — Nov 2022 [monthly]

    Recruiting PHASE1

    First recorded

Dec 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • IGM Biosciences, Inc.
Data source: IGM Biosciences, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations